Increased Circulating CD4⁺CXCR5⁺ Cells and IgG4 Levels in Patients with Myelodysplastic Syndrome with Autoimmune Diseases

Figure 4

The change of serum IgG of newly diagnosed MDS-AI (PRE) and post-therapy (POST). (a) The change of serum IgG4 of newly diagnosed MDS-AI (PRE) and posttherapy (POST). (b) The change of serum IgG of newly diagnosed MDS-AI (PRE) and posttherapy (POST). (c) The fraction of serum IgG4/IgG of newly diagnosed MDS-AI (PRE) and posttherapy (POST) ().

(a)

(b)

(c)